OMV AG/ AT0000743059 /
1/2/2025 5:35:29 PM | Chg. +1.100 | Volume | Bid5:45:00 PM | Ask1/2/2025 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
38.440EUR | +2.95% | 447,937 Turnover: 17.16 mill. |
-Bid Size: - | -Ask Size: - | 12.57 bill.EUR | 13.14% | 8.49 |
GlobeNewswire
3/26/2024
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16/2024
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center